Labshake search
Citations for Bio X Cell :
1 - 50 of 120 citations for 4 Methylcaprolactam since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2021Quote: ... and anti-IL-4 (BioXCell); for Th2 ...
-
bioRxiv - Immunology 2020Quote: ... LFA blocking antibody (M17/4; BioXCell) was administered i.p ...
-
bioRxiv - Cancer Biology 2020Quote: ... and anti-CTLA-4 (BioXCell, BE0164) or isotype control (MSD IgG1 control for muDX400 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BioXCell # BE0164) were diluted in PBS and dosed at 10 mg/kg every 3 days ...
-
bioRxiv - Immunology 2024Quote: ... and IL-4-reactive monoclonal antibodies for in vivo studies (IL-4 MAb) were purchased from BioXCell (BE0045). All TLR agonists were purchased from Invivogen ...
-
bioRxiv - Immunology 2019Quote: ... anti-IL-4 (BioXcell, 11B11, 10ug/mL), IL-12 (Peprotech ...
-
bioRxiv - Cancer Biology 2021Quote: ... and anti-4-1BB (clone LOB12.3, BioXCell) treatment ...
-
bioRxiv - Immunology 2022Quote: ... and 3μg/mL anti–IL-4 (BioXcell) were used ...
-
bioRxiv - Immunology 2023Quote: Studies of anti-CTLA-4 (BE0032, BioXcell) therapy in mice bearing CT26 and B16 tumors ...
-
bioRxiv - Immunology 2022Quote: ... Inhibition of CTLA-4 signaling was performed by intraperitoneal injection of 500μg/dose of αCTLA-4 (clone: UC10-4F10-11, BioXcell) supplemented with 1mg/dose of IgG2b isotype (clone ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (10 µg/ml, BioXCell). Th1 cells were then cultured ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone: UC10-4F10-11, BioXcell) or isotype control antibodies (clone ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Immunology 2023Quote: ... and anti-IL-4 Ab (clone 11B11, BioXCell) at a concentration of 10 µg/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 4 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Immunology 2022Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-IL-6 or anti-CTLA-4 antibodies (BioXCell). For CXCR3 blockade studies ...
-
bioRxiv - Immunology 2021Quote: ... anti–mIL-4 (8 μg/mL, Bio X Cell), and anti–mIFN-γ (8 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... and anti-IL-4 (clone 11B11, Bio X Cell). Briefly ...
-
bioRxiv - Immunology 2022Quote: ... 15 and αCTLA-4 (9H10; BioXcell; 200 μg/dose) on days 0 ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-4-1BB (clone LOB12.3, Bio X Cell #BP0169), anti-PD-1 (clone 29F.1A12 ...
-
bioRxiv - Immunology 2021Quote: ... and CTLA-4 blocking antibody (clone 9D9, BioXCell, cat. BE0164) were administered either in combination or as single agents at 100ug/antibody/mouse every third day starting on the day of doxycycline diet addition for four total doses.
-
bioRxiv - Microbiology 2020Quote: ... and 25 μg of anti-IL-4 (BioXcell, clone 11B11) were complexed prior to intraperitoneally injection into mice ...
-
bioRxiv - Cancer Biology 2019Quote: ... mice were randomized and treated with αCTLA-4 (BioXCell, BP0164) or isotype control (BioXcell ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-4-1BB agonist (5 mg/kg, clone: 3H3, BioXcell), or anti-PD-1 (10 mg/kg ...
-
bioRxiv - Immunology 2021Quote: ... TREG conditions: anti–IL-4 (10 μg/mL, BioXCell, #BE0045), anti-IFN-γ (10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... and 10 μg/mL a-IL-4 (clone 11B11, BioXCell). For Th17 conditions ...
-
bioRxiv - Immunology 2023Quote: ... Tumor-bearing mice were treated with anti-CTLA-4 (BioXCell) (n=8 ...
-
bioRxiv - Cancer Biology 2024Quote: ... and anti-CTLA-4 (clone 9D9, Bio X Cell, #BE0164) were performed as part of this study ...
-
bioRxiv - Immunology 2021Quote: ... plus 2 µg/mL anti-IL-4 antibody (BioXcell, Clone: 11B11); Th17 ...
-
bioRxiv - Immunology 2019Quote: ... αIL-4 (5 μg mL−1, clone 11B11; Bio X Cell), rhTGF-β1 (2 ng mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... complexed to 25 μg anti-IL-4 antibody (clone 11B11; BioXcell) in 100 μL sterile Phosphate buffered saline (PBS ...
-
bioRxiv - Immunology 2023Quote: ... In some studies 100µg anti-LFA-1α (clone M17/4, BioXcell), 100µg rat IgG2a isotype control (BioXcell) ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 200 ug anti-CTLA-4 (BioXcell, catalog #BE0164, clone 9D9) at days 9 and 12 after organoid implantation ...
-
bioRxiv - Microbiology 2024Quote: ... was mixed with 25 μg anti-IL-4 (Clone 11B11, BioXCell) and incubated for 1-5 min prior to diluting to 200 μl total volume in PBS ...
-
bioRxiv - Immunology 2024Quote: ... cells were stained with VL-4 rat anti-LCMV nucleoprotein (BioXCell), followed by staining with anti-rat horseradish peroxidase (Jackson Immunoresearch ...
-
bioRxiv - Immunology 2024Quote: ... and 200µg of anti-mouse CTLA-4 antibody (9H10 clone, BioXCell), using purified Rat IgG2a,κ isotype control antibody (RTK2758 clone ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 75µg of anti-CTLA-4 (9H10) antibody or IgG equivalent (BioXCell). Treatments continued every three days until the end of the experiment (maximum tumor growth of 15 mm diameter for control groups) ...
-
bioRxiv - Immunology 2022Quote: ... mice were treated with 250 ug/dose of CTLA-4 Ig (BioXCell) and anti-ICOS (BioXCell ...
-
bioRxiv - Immunology 2021Quote: ... the medium was supplemented with anti-IL-4 antibody (BioXcell; clone 11B11). On day 5 ...
-
bioRxiv - Genomics 2022Quote: ... 10 μg/mL of anti-IL-4 (Clone: 11B11, BioXCell, Cat# BE0045), 2 ng/mL of recombinant TGFβ (BioLegend ...
-
bioRxiv - Immunology 2023Quote: ... or 4-1BB (5 µg/ml, clone 3H3, BE0239) all from BioXCell. Unless otherwise stated ...
-
bioRxiv - Immunology 2023Quote: ... and 100 μg monoclonal antibody to integrin αL (clone M17/4; BioXCell) and sacrificed eight hours later.
-
bioRxiv - Cancer Biology 2023Quote: ... and/or 200 μg/mouse αCTLA-4 (BioXcell, catalog #BE0164, clone 9D9) i.p ...
-
bioRxiv - Immunology 2023Quote: ... 500 µg of anti-CTLA-4 antibody (clone UC10-4F10-11, BioXCell) or hamster IgG isotype control antibody (clone PIP ...
-
bioRxiv - Cancer Biology 2021Quote: ... 250 μg PD-1 and CTLA-4 blocking (clone 9H10, BioXCell, Lebanon, NH) antibodies were injected intraperitoneally thrice per week for four weeks or a combination of PD-1 CTLA-4 antibodies with iBET762 were used.
-
bioRxiv - Cancer Biology 2020Quote: ... or isotype control (MSD IgG1 control for muDX400, BioXCell, BE0086 for CTLA-4) treatments were administered on days 0 ...
-
bioRxiv - Immunology 2024Quote: ... and 10 μg/ml of anti-IL-4 mAb (#BE0045, BioXCell, Lebanon, NH); (c ...